447 related articles for article (PubMed ID: 32169218)
1. Tumor-Derived Retinoic Acid Regulates Intratumoral Monocyte Differentiation to Promote Immune Suppression.
Devalaraja S; To TKJ; Folkert IW; Natesan R; Alam MZ; Li M; Tada Y; Budagyan K; Dang MT; Zhai L; Lobel GP; Ciotti GE; Eisinger-Mathason TSK; Asangani IA; Weber K; Simon MC; Haldar M
Cell; 2020 Mar; 180(6):1098-1114.e16. PubMed ID: 32169218
[TBL] [Abstract][Full Text] [Related]
2. Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment.
Lam KC; Araya RE; Huang A; Chen Q; Di Modica M; Rodrigues RR; Lopès A; Johnson SB; Schwarz B; Bohrnsen E; Cogdill AP; Bosio CM; Wargo JA; Lee MP; Goldszmid RS
Cell; 2021 Oct; 184(21):5338-5356.e21. PubMed ID: 34624222
[TBL] [Abstract][Full Text] [Related]
3. A unique anti-CD115 monoclonal antibody which inhibits osteolysis and skews human monocyte differentiation from M2-polarized macrophages toward dendritic cells.
Haegel H; Thioudellet C; Hallet R; Geist M; Menguy T; Le Pogam F; Marchand JB; Toh ML; Duong V; Calcei A; Settelen N; Preville X; Hennequi M; Grellier B; Ancian P; Rissanen J; Clayette P; Guillen C; Rooke R; Bonnefoy JY
MAbs; 2013; 5(5):736-47. PubMed ID: 23924795
[TBL] [Abstract][Full Text] [Related]
4. Tuning the Tumor Myeloid Microenvironment to Fight Cancer.
Jahchan NS; Mujal AM; Pollack JL; Binnewies M; Sriram V; Reyno L; Krummel MF
Front Immunol; 2019; 10():1611. PubMed ID: 31402908
[TBL] [Abstract][Full Text] [Related]
5. IKKα-deficient lung adenocarcinomas generate an immunosuppressive microenvironment by overproducing Treg-inducing cytokines.
Song NY; Li X; Ma B; Willette-Brown J; Zhu F; Jiang C; Su L; Shetty J; Zhao Y; Shi G; Banerjee S; Wu X; Tran B; Nussinov R; Karin M; Hu Y
Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35121655
[TBL] [Abstract][Full Text] [Related]
6. Continuous retinoic acid induces the differentiation of mature regulatory monocytes but fails to induce regulatory dendritic cells.
VanGundy ZC; Guerau-de-Arellano M; Baker JD; Strange HR; Olivo-Marston S; Muth DC; Papenfuss TL
BMC Immunol; 2014 Feb; 15():8. PubMed ID: 24548459
[TBL] [Abstract][Full Text] [Related]
7. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
[TBL] [Abstract][Full Text] [Related]
8. Retinoic acid: a key player in immunity.
Pino-Lagos K; Guo Y; Noelle RJ
Biofactors; 2010; 36(6):430-6. PubMed ID: 20803520
[TBL] [Abstract][Full Text] [Related]
9. Targeting macrophage Syk enhances responses to immune checkpoint blockade and radiotherapy in high-risk neuroblastoma.
Rohila D; Park IH; Pham TV; Jones R; Tapia E; Liu KX; Tamayo P; Yu A; Sharabi AB; Joshi S
Front Immunol; 2023; 14():1148317. PubMed ID: 37350973
[TBL] [Abstract][Full Text] [Related]
10. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
[TBL] [Abstract][Full Text] [Related]
11. Delivery of TLR7 agonist to monocytes and dendritic cells by DCIR targeted liposomes induces robust production of anti-cancer cytokines.
Klauber TCB; Laursen JM; Zucker D; Brix S; Jensen SS; Andresen TL
Acta Biomater; 2017 Apr; 53():367-377. PubMed ID: 28153581
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid contributes to the induction of IL-12-hypoproducing dendritic cells.
Wada Y; Hisamatsu T; Kamada N; Okamoto S; Hibi T
Inflamm Bowel Dis; 2009 Oct; 15(10):1548-56. PubMed ID: 19340880
[TBL] [Abstract][Full Text] [Related]
13. IL-27 Negatively Regulates Tip-DC Development during Infection.
Liu G; Abas O; Fu Y; Chen Y; Strickland AB; Sun D; Shi M
mBio; 2021 Feb; 12(1):. PubMed ID: 33593983
[TBL] [Abstract][Full Text] [Related]
14. Treg Cells Promote the SREBP1-Dependent Metabolic Fitness of Tumor-Promoting Macrophages via Repression of CD8
Liu C; Chikina M; Deshpande R; Menk AV; Wang T; Tabib T; Brunazzi EA; Vignali KM; Sun M; Stolz DB; Lafyatis RA; Chen W; Delgoffe GM; Workman CJ; Wendell SG; Vignali DAA
Immunity; 2019 Aug; 51(2):381-397.e6. PubMed ID: 31350177
[TBL] [Abstract][Full Text] [Related]
15. IL-32γ potentiates tumor immunity in melanoma.
Gruber T; Kremenovic M; Sadozai H; Rombini N; Baeriswyl L; Maibach F; Modlin RL; Gilliet M; von Werdt D; Hunger RE; Seyed Jafari SM; Parisi G; Abril-Rodriguez G; Ribas A; Schenk M
JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32841222
[TBL] [Abstract][Full Text] [Related]
16. Th1 polarization in the tumor microenvironment upregulates the myeloid-derived suppressor-like function of macrophages.
Nonaka K; Saio M; Umemura N; Kikuchi A; Takahashi T; Osada S; Yoshida K
Cell Immunol; 2021 Nov; 369():104437. PubMed ID: 34530344
[TBL] [Abstract][Full Text] [Related]
17. The tumour microenvironment harbours ontogenically distinct dendritic cell populations with opposing effects on tumour immunity.
Laoui D; Keirsse J; Morias Y; Van Overmeire E; Geeraerts X; Elkrim Y; Kiss M; Bolli E; Lahmar Q; Sichien D; Serneels J; Scott CL; Boon L; De Baetselier P; Mazzone M; Guilliams M; Van Ginderachter JA
Nat Commun; 2016 Dec; 7():13720. PubMed ID: 28008905
[TBL] [Abstract][Full Text] [Related]
18. Lost therapeutic potential of monocyte-derived dendritic cells through lost tissue homing: stable restoration of gut specificity with retinoic acid.
Bernardo D; Mann ER; Al-Hassi HO; English NR; Man R; Lee GH; Ronde E; Landy J; Peake ST; Hart AL; Knight SC
Clin Exp Immunol; 2013 Oct; 174(1):109-19. PubMed ID: 23607934
[TBL] [Abstract][Full Text] [Related]
19. Monocytes and dendritic cells in a hypoxic environment: Spotlights on chemotaxis and migration.
Bosco MC; Puppo M; Blengio F; Fraone T; Cappello P; Giovarelli M; Varesio L
Immunobiology; 2008; 213(9-10):733-49. PubMed ID: 18926289
[TBL] [Abstract][Full Text] [Related]
20. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
[Next] [New Search]
